Validation Study of Exiqon's miRCURY LNA(TM) Universal RT microRNA PCR Product Line Concludes that Exiqon's PCR Products Are 10 Times as Sensitive as the Comparable Products Provided by Main Competitor.
In: GlobeNewswire, 2010-11-02
Zeitungsartikel
Zugriff:
Titel: |
Validation Study of Exiqon's miRCURY LNA(TM) Universal RT microRNA PCR Product Line Concludes that Exiqon's PCR Products Are 10 Times as Sensitive as the Comparable Products Provided by Main Competitor.
|
---|---|
Zeitschrift: | GlobeNewswire, 2010-11-02 |
Veröffentlichung: | 2010 |
Medientyp: | Zeitungsartikel |
Sonstiges: |
|